Hormonal
Hepatocyte-specific deletion of MyD88 causes glucose intolerance, hepatic insulin resistance, and inflammation independently of body weight or fat mass gain.
This research highlights that liver-specific immune signaling (MyD88) is crucial for maintaining glucose and lipid balance. While you cannot change your genetics, understanding that liver health is distinct from body weight is key. High-fat diets can unmask or worsen underlying liver metabolic vulnerabilities, even in lean individuals. Focus on liver-supportive lifestyle choices (balanced diet, exercise) to mitigate genetic risks.
Hepatocyte-specific deletion of MyD88 predisposes to glucose intolerance, inflammation and hepatic insulin resistance independently of body weight and adiposity.
Why this rating
High-quality mechanistic data in a well-controlled mouse model with human validation, but not a clinical trial.
Source
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
Thibaut Duparc et al. · Gut · 2016
DOI 10.1136/gutjnl-2015-310904
More from this paper
- Hepatocyte MyD88 regulates bile acid synthesis and profile, which in turn influences gut microbiota composition and host glucose/lipid metabolism.Good
- Obese humans with Non-Alcoholic Steatohepatitis (NASH) exhibit decreased expression of cytochromes P450 involved in bioactive lipid synthesis, mirroring findings in MyD88-deficient mice.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →